News

Filter

Current filters:

None

10 to 19 of 97230 results

Link between immune system and brain diseases to be researched by Lundbeck

22-12-2014

Danish CNS specialist drugmaker Lundbeck is involved in new groundbreaking research that will investigate…

ImmunologicalsJanssenLundbeckNeurologicalPharmaceuticalResearch

Roche shares fall sharply on disappointing Ph III MARIANNE study

Roche shares fall sharply on disappointing Ph III MARIANNE study

22-12-2014

Swiss pharma major Roche saw its shares plunge 6.4% to 270.40 Swiss francs on Friday following release…

BiotechnologyGenentechHerceptinKadcylaOncologyPerjetaRoche

New Indian moves on pharma pricing

New Indian moves on pharma pricing

22-12-2014

Early January 2015, the Indian government is to come out with a new list of life saving drugs whose prices…

GenericsPoliticsPricing

AstraZeneca’s Lynparza gains FDA approval

AstraZeneca’s Lynparza gains FDA approval

20-12-2014

The US Food and Drug Administration has granted accelerated approved for Anglo-Swedish drug major AstraZeneca’s…

AstraZenecaLynparzaOncologyPharmaceuticalRegulationUSA

FDA approves fourth hepatitis C drug, AbbVie’s Viekira Pak

FDA approves fourth hepatitis C drug, AbbVie’s Viekira Pak

20-12-2014

The US Food and Drug Administration on Friday confirmed the much anticipated approval of US pharma company…

AbbVieAnti-viralsPharmaceuticalRegulationUSAViekira Pak

FDA approves new antibacterial drug Zerbaxa

20-12-2014

The US Food and Drug Administration has approved Cubist Pharmaceuticals’Zerbaxa (ceftolozane/tazobactam)…

Antibiotics and Infectious diseasesCubist PharmaceuticalsMerck & CoPharmaceuticalRegulationUSAZerbaxa

Bina Technologies is acquired by Roche

20-12-2014

Swiss pharma giant Roche has acquired Bina Technologies, a privately held company based in Redwood City,…

Bina TechnologiesBiotechnologyMergers & AcquisitionsRoche

RXi and Hapten enter into licensing agreement for Samcyprone

RXi and Hapten enter into licensing agreement for Samcyprone

19-12-2014

RNA technology specialist RXi Pharmaceuticals Corp has entered into a global licensing agreement with…

BiotechnologyDermatologicalsLicensingNeurologicalRXi Pharmaceuticals

Cuba a huge opportunity for life sciences, says Abivax

Cuba a huge opportunity for life sciences, says Abivax

19-12-2014

Paris-based antiviral specialist Abivax has spoken in praise of the decision between the USA and Cuba…

ABIVAXABIVAXCubaPharmaceuticalUnited States

10 to 19 of 97230 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top